Delivery Order SPE2DB22D1106-SPE2DB24FEAC0
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,643.58 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Atorvastatin 5-40 mg in quantities of 30 units. This non-set-aside, competitively awarded delivery order is priced on a firm fixed price basis with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of December 23, 2025. The award was issued on December 22, 2025, and represents a pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Amlodipine-Atorvastatin 10-20 mg in 30-count packages. This firm fixed-price delivery order, valued at $3,920.43, is a non-set-aside competitive award supporting federal medical procurement needs. The contract represents performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $2,837.70 contract is to provide AMLODIPINE-VALSARTAN 5-160 MG 30S medication to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies under contract 4569914827, valued at $1,024.14 with a firm fixed price structure. The specific delivery involves AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a combination antihypertensive medication, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $19,138.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,745.76, is for the delivery of AMLODIPINE-VALSARTAN 10-320 mg 30-count tablets. This is a firm fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
- This $4,759.35 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract provides for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, with a completion date of August 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' healthcare...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,011.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TELMISARTAN-AMLODIPINE 80-10 30S medication. This delivery order contract has a completion date of January 31, 2024 and was awarded on January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used for this award. This...
- The Defense Logistics Agency awarded a $1,337.76 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG in a 30-count package. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...